Home › Funds › Boston Trust Walden Corp › JAZZ

Boston Trust Walden Corp position in JAZZ

JAZZ PHARMACEUTICALS PLC · Health Care

Boston Trust Walden Corp reported holding 424,569 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$98.3M, representing 0.79% of its reported portfolio and ranking #24 among its reported holdings. Boston Trust Walden Corp has disclosed JAZZ holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)424.57K sh
Reported value held$98.30M
Portfolio Weight0.79%
First reportedQ1 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Boston Trust Walden Corp's JAZZ position evolved

Boston Trust Walden Corp first disclosed a stake in JAZZ in Q1 2025 at 178,012 shares (US$22.1M). The position peaked in Q2 2026 at 443,123 shares, worth US$106.8M. Across 7 filings, Boston Trust Walden Corp increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 424,569 shares valued at US$98.3M — a reduction of -18,554 shares quarter over quarter.. Notable position changes include a 129% increase in Q2 2025 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 178.01K $22.10M New
Q2 2025 407.90K $43.29M Add
Q3 2025 408.83K $53.88M Hold
Q4 2025 393.91K $66.96M Reduce
Q1 2026 488.66K $92.38M Add
Q2 2026 443.12K $106.78M Reduce
Q3 2026 424.57K $98.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JAZZ and 13F data

JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 41 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JAZZ

All JAZZ fund holders →

FAQ

How long has Boston Trust Walden Corp held JAZZ?

Boston Trust Walden Corp has disclosed JAZZ holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Boston Trust Walden Corp's current position in JAZZ?

As of Q3 2026, Boston Trust Walden Corp holds 424.57K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $98.30M, representing 0.79% of its reported portfolio and ranking #24.

Has Boston Trust Walden Corp been buying or selling JAZZ?

In the latest 13F filing (Q3 2026), Boston Trust Walden Corp reduced its position in JAZZ. The position peaked in Q2 2026 at 443.12K shares.

Which other funds hold JAZZ?

Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.